Jonathan Wren to Biomarkers, Tumor
This is a "connection" page, showing publications Jonathan Wren has written about Biomarkers, Tumor.
Connection Strength
1.065
-
Experimental validation of 5 in-silico predicted glioma biomarkers. Neuro Oncol. 2013 Dec; 15(12):1625-34.
Score: 0.358
-
ELTD1, a potential new biomarker for gliomas. Neurosurgery. 2013 Jan; 72(1):77-90; discussion 91.
Score: 0.338
-
A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer. BMC Cancer. 2019 May 06; 19(1):423.
Score: 0.131
-
Predictive bioinformatics identifies novel regulators of proliferation in a cancer stem cell model. Stem Cell Res. 2018 01; 26:1-7.
Score: 0.119
-
Prioritizing uncharacterized genes in the search for glioma biomarkers. CNS Oncol. 2014 Mar; 3(2):93-5.
Score: 0.092
-
Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia. Hum Genomics. 2016 07 25; 10 Suppl 2:18.
Score: 0.027